Saturday, October 31, 2026

Primerica, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

January 13, 2021

Primerica, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Danaher Corporation

35.8% sales growth and 8.99% return on equity

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.

Danaher Corporation's sales growth this year is expected to be 22.7% and 15.8% for next year.

Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 20.39B for the twelve trailing months.

Danaher Corporation's sales growth for the next quarter is 35.8%. The company's growth estimates for the present quarter and the next is 43% and 54.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.99%.

Volatility

Danaher Corporation's last day, last week, and last month's average volatility was 1.42%, 1.67%, and 0.28%, respectively.

Danaher Corporation's last day, last week, and last month's high and low average amplitude percentage was 2.17%, 3.18%, and 2.14%, respectively.

Danaher Corporation's Stock Yearly Top and Bottom Value

Danaher Corporation's stock is valued at $239.71 at 19:22 EST, under its 52-week high of $248.32 and way higher than its 52-week low of $119.60.

Danaher Corporation's Moving Average

Danaher Corporation's value is above its 50-day moving average of $223.97 and way higher than its 200-day moving average of $211.92.

2. Citizens & Northern Corp

31.7% sales growth and 6.64% return on equity

Citizens & Northern Corporation operates as the bank holding company for Citizens & Northern Bank that provides a range of banking and mortgage services to individual and corporate customers in North Central Pennsylvania and Southern New York.

Citizens & Northern Corp's sales growth this year is anticipated to be 23% and 7.7% for next year.

Year-on-year quarterly revenue growth grew by 34.5%, now sitting on 81.03M for the twelve trailing months.

Citizens & Northern Corp's sales growth for the next quarter is 31.7%. The company's growth estimates for the ongoing quarter and the next is a negative 8.7% and negative -7.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.64%.

Volatility

Citizens & Northern Corp's last day, last week, and last month's average volatility was a negative 1.78%, a positive 0.98%, and a positive 0.25%, respectively.

Citizens & Northern Corp's last day, last week, and last month's high and low average amplitude percentage was 5.58%, 4.72%, and 3.20%, respectively.

Citizens & Northern Corp's Stock Yearly Top and Bottom Value

Citizens & Northern Corp's stock is valued at $20.76 at 19:22 EST, way under its 52-week high of $28.87 and way higher than its 52-week low of $14.92.

Citizens & Northern Corp's Moving Average

Citizens & Northern Corp's worth is above its 50-day moving average of $19.54 and way above its 200-day moving average of $18.19.

3. Allegiance Bancshares, Inc.

27.3% sales growth and 5.97% return on equity

Allegiance Bancshares, Inc. operates as the bank holding company for Allegiance Bank that provides a range of commercial banking services primarily to small and medium-sized businesses, professionals, and individual customers.

Allegiance Bancshares, Inc.'s sales growth this year is expected to be 9.3% and 1.6% for next year.

Year-on-year quarterly revenue growth grew by 16.1%, now sitting on 177.9M for the twelve trailing months.

Allegiance Bancshares, Inc.'s sales growth for the next quarter is 27.3%. The company's growth estimates for the present quarter and the next is 6% and 411.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.97%.

Volatility

Allegiance Bancshares, Inc.'s last day, last week, and last month's average volatility was 1.07%, 0.25%, and 0.22%, respectively.

Allegiance Bancshares, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.32%, 2.78%, and 3.06%, respectively.

Allegiance Bancshares, Inc.'s Stock Yearly Top and Bottom Value

Allegiance Bancshares, Inc.'s stock is valued at $34.13 at 19:22 EST, way below its 52-week high of $38.95 and way higher than its 52-week low of $20.88.

Allegiance Bancshares, Inc.'s Moving Average

Allegiance Bancshares, Inc.'s value is higher than its 50-day moving average of $33.30 and way higher than its 200-day moving average of $27.19.

4. Primerica, Inc.

9.3% sales growth and 22.81% return on equity

Primerica, Inc., together with its subsidiaries, provides financial products to middle income households in the United States and Canada.

Primerica, Inc.'s sales growth this year is anticipated to be 7.6% and 9.3% for next year.

Year-on-year quarterly revenue growth grew by 9.3%, now sitting on 2.21B for the twelve trailing months.

Primerica, Inc.'s sales growth for the next quarter is 9.3%. The company's growth estimates for the ongoing quarter and the next is 12.2% and 16.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.81%.

Volatility

Primerica, Inc.'s last day, last week, and last month's average volatility was a negative 0.46%, a positive 0.36%, and a negative 0.09%, respectively.

Primerica, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.83%, 3.33%, and 2.56%, respectively.

Primerica, Inc.'s Stock Yearly Top and Bottom Value

Primerica, Inc.'s stock is valued at $136.31 at 19:22 EST, below its 52-week high of $141.15 and way above its 52-week low of $61.20.

Primerica, Inc.'s Moving Average

Primerica, Inc.'s worth is above its 50-day moving average of $134.97 and way higher than its 200-day moving average of $123.58.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com